Powder Delivery TRIZ Cases

Administers IL-15 alongside MEK inhibitors to reverse T cell suppression, reducing myeloid-derived suppressor cells for durable tumor rejection.

Replacing polysorbate with mannitol and histidine buffers prevents oxidation and aggregation in anti-AXL antibody-drug conjugates.

Microwave irradiation selectively converts precursor ginsenosides to boost Rg5 and Rk1 ratios, overcoming low yields from conventional thermal heating.

Segmented inner and outer compartments protect incompatible payloads from degradation while enabling temporal control of release to macrophages.

Segmented dosage containers with distinct identifiers resolve the trade-off between dosing precision and device complexity in oral immunotherapy.

Allergen dosage units combine antihistamines to relieve oral mucosal itching during administration.

A curcumin nanoparticle with a gum arabic and zein wall material resolves poor water solubility and light degradation issues.

A pharmaceutical composition uses sucrose, amino acids, and a surfactant to stabilize antibodies during lyophilization.

Directional binding of fibrous polypeptides to polysaccharides overcomes protein aggregation during spider silk production.

Dual release layers with distinct solubility enable precise nanoparticle separation, minimizing distortion and separation defects during lift-off.

Combining multiple allergen sources induces IgG4 production and reduces Th2 proliferation to prevent anaphylactic reactions.

A fixed-dose pharmaceutical combination merges a glucokinase activator with a biguanide to enhance hypoglycemic efficacy.

Extracellular matrix adjuvant enhances anti-tumor activity by stimulating protective immune response against ovarian cancer cells.

Porous silica carriers adsorb mRNA to resolve stability trade-offs, enabling rapid development while maintaining effectiveness across temperatures.

A chitosan glycerophosphate hydrogel delivers therapeutic agents directly to the inner ear via the round window membrane.

Administering 1-8 units of chondroitinase ABC per disk reduces nerve root pressure while preserving disc cushion function.

Electron beam cross-linking dextran and poloxamer creates thermoresponsive hydrogels that resolve biocompatibility versus biodegradability trade-offs.

Segmented L-menthol beads with proteinaceous subcoatings prevent premature gastric release and stomach irritation.

Lyophilizing exosomes in a trehalose buffer preserves structural integrity, enabling long-term ambient storage without cold chain requirements.

A porous demineralized bone matrix sheet retains particulate collagen and DBM within an ionically crosslinked polysaccharide gel structure.

Composite nicotine and FDKP microparticles deliver drugs to the lungs, reducing exhalation and secondhand smoke.

Isosorbide polyoxyethylene fatty acid esters replace degrading polysorbates to prevent amino acid oxidation and preserve protein biological activity.

Surface-displayed ACE2 on exosomes binds SARS-CoV-2 spike proteins, blocking viral entry while maintaining manufacturing simplicity through segmentation.

Peptide p1978 overcomes limited treatment effectiveness in triple negative breast cancer by inducing cell death via Ras pathway interaction.

PLGA microspheres encapsulate hCG protein to enable sustained release, reducing injection frequency and improving stability.

Magnetic fields excite paramagnetic nanoparticles to modulate ion flow, replacing invasive implants with non-invasive remote control.

Selenium-containing modifying agents form stable selenide bonds with protein thiols, solving disulfide instability in G-CSF pegylation.

A magnetic nanoscreen reversibly adjusts its nanogap via external fields to control ligand accessibility.

Fluorogenic sensor conjugates release fluorescent molecules upon oxidation, resolving poor washout kinetics and low specificity of conventional probes.

Albumin-encapsulated Yb-Er nanoparticles emit short-wave infrared light, reducing tissue autofluorescence and improving imaging reliability.

Hydrophilic impregnating agents reduce resin swelling to prevent coating rupture, enabling 24-hour drug release without organic solvents.

A solid dispersion converts crystalline 3β-hydroxyurs-12-en-28-oic acid to an amorphous form using low-temperature melt extrusion.

A ternary solvent system prevents phase separation in biodegradable microspheres, maintaining uniform drug loading without surfactants.

Buffer titration of dissolved insulin yields high-purity particles, resolving low purity and suboptimal particle size issues.

Hydrolytically unstable linkages enable controlled scaffold degradation, resolving the trade-off between mechanical strength and tissue integration.

A nanoparticle system covalently bonds active molecules with hyaluronidase enzymes to enable precise, controlled release of therapeutic agents.

HPV L1 nanosphere particles encapsulate drugs in a core-shell structure to target tumor cells while avoiding damage to healthy dividing tissue.

Oral probiotic composition reduces pro-inflammatory interleukins and side effects while improving dry sensitive skin conditions.

CEND-1 peptide mediates deep tumor penetration for chemotherapeutics, overcoming limited vascular diffusion and improving efficacy.

An anionic polymer interface enables mineralization of inorganic materials onto protein templates for biomaterial scaffolds.

Replacing toxic lectins, cross-linked aptamer materials detect glucose concentrations to enable precise, proportional insulin release.

Covalently crosslinked albumin and polyethylene glycol nanoparticles maintain saline stability while eliminating toxic solvent contamination.

Polyalkylene oxide particles with controlled size distribution enhance compression molding properties and reduce tablet friability.

Covalently attaching bacteriophages to carrier particles prevents rapid clearance and enhances stability during systemic treatment.

Hyaluronidase mediates subcutaneous enzyme distribution, bypassing complex intravenous infusion systems while reducing hypersensitivity risks.

Composite spray-dried particles resolve powder flow contradictions by pairing fine lung-targeting drugs with larger carrier structures.

A pulverulent crystalline maltitol composition uses a hygroscopic water-insoluble anti-caking agent to prevent caking while preserving dissolution speed.

Triphenylamine-combined benzothiadiazole conjugated with luminol generates near-infrared chemiluminescence.